Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
229 hedge funds and large institutions have $3.16B invested in Cantel Medical Corporation in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 74 increasing their positions, 72 reducing their positions, and 17 closing their positions.
194% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 17
76% more capital invested
Capital invested by funds: $1.79B → $3.16B (+$1.37B)
17% more funds holding
Funds holding: 196 → 229 (+33)
3% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 72
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
29% less call options, than puts
Call options by funds: $3.21M | Put options by funds: $4.52M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$21.7M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$20.6M |
| 3 |
BlackRock
New York
|
+$19.5M |
| 4 |
JP Morgan Chase
New York
|
+$17M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$16.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$51.4M |
| 2 |
LGP
Leonard Green & Partners
Los Angeles,
California
|
-$29.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$22.6M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$14.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.5M |
CMD Hedge Fund Activity: Q4 2020 in Review
229 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q4 2020, worth a combined $3.16B — up 76% from $1.79B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new CMD positions and 17 closed out — a net gain of 33 holders — while 74 added to existing stakes and 72 trimmed.
The largest buyer was VOYA Investment Management, adding an estimated $21.7M. The largest seller was Mackenzie Financial, exiting entirely with an estimated $51.4M sold.
- 229 institutional investors held Cantel Medical Corporation (CMD) as of Q4 2020, up from 196 in Q3 2020.
- Funds reported $3.16B of Cantel Medical Corporation stock for Q4 2020, up 76% quarter-over-quarter.
- 50 funds opened new Cantel Medical Corporation positions in Q4 2020 and 17 closed out, a net change of +33 holders.
- The largest Cantel Medical Corporation buyer in Q4 2020 was VOYA Investment Management, an estimated $21.7M added.
- The largest Cantel Medical Corporation seller in Q4 2020 was Mackenzie Financial, an estimated $51.4M sold.
Based on aggregated 13F filings for Q4 2020.